# Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/olaparib-tablets-as-maintenance-therapy-in-patients-with-platinum-sensitive/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Éric Pujade-Lauraine,Jonathan A. Ledermann,Frédèric Selle,Val Gebski,Richard T. Penson,Amit M. Oza,Jacob Korach,Tomasz Huzarski,Andrés Poveda,Sandro Pignata,Michael Friedländer,Nicoletta Colombo,Philipp Harter,Keiichi Fujiwara,Isabelle Ray‐Coquard,Susana Banerjee,Joyce F. Liu,Elizabeth Lowe,Ralph Bloomfield,Patricia Pautier,Jacob Korach,Tomasz Huzarski,Tomasz Byrski,Patricia Pautier,Michael Friedländer,Philipp Harter,Nicoletta Colombo,Sandro Pignata,Giovanni Scambia,Maria Ornella Nicoletto,Fiona Nussey,Andrew R. Clamp,Richard T. Penson,Amit M. Oza,A. Poveda Velasco,Manuel Rodrigues,Jean‐Pierre Lotz,Frédèric Selle,Isabelle Ray‐Coquard,Diane Provencher,Aleix Prat Aparicio,Laura Vidal Boixader,Clare L. Scott,Kenji Tamura,Mayu Yunokawa,Alla Lisyanskaya,Jacques Médioni,Nicolas Pécuchet,Coraline Dubot,Thibault De La Motte Rouge,Marie‐Christine Kaminsky,B. Weber,Alain Lortholary,Christine Parkinson,Jonathan A. Ledermann,Sarah Williams,Susana Banerjee,Jonathan A. Cosin,James Hoffman,Richard T. Penson,Marie Plante,Allan Covens,Gabe S. Sonke,Florence Joly,Anne Floquet,Susana Banerjee,Holger W. Hirte,Amnon Amit,Tjoung-Won Park-Simon,Koji Matsumoto,Sergei Tjulandin,Jae‐Hoon Kim,Laurence Gladieff,Roberto Sabbatini,David M. O’Malley,Patrick Timmins,Daniel Kredentser,Nuria Laínez Milagro,M.P. Barretina Ginesta,Ariadna Tibau Martorell,Alfonso Gómez de Liaño,Belén Ojeda González,Linda Mileshkin,Masaki Mandai,Ingrid Boere,Petronella B. Ottevanger,Joo‐Hyun Nam,Elias Abdo Filho,Salima Hamizi,Francesco Cognetti,David Warshal,Elizabeth Dickson-Michelson,Scott Kamelle,Nathalie D. McKenzie,Gustavo C. Rodriguez,Deborah K. Armstrong,Eva Chalas,Paul Celano,Kian Behbakht,Susan A. Davidson |
| Citations | 1,881 |
| DOI | 10.1016/s1470-2045(17)30469-2 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2737389832 |
| PMID | 28754483 |
| Type | article |
| Year | 2017 |

## Paper authors

- [David M. O’Malley](https://scholariq.org/researchers/david-m-o-malley/)
- [Michael Friedländer](https://scholariq.org/researchers/michael-friedlander/)
- [Giovanni Scambia](https://scholariq.org/researchers/giovanni-scambia/)
- [Amit M. Oza](https://scholariq.org/researchers/amit-m-oza/)
- [Nicoletta Colombo](https://scholariq.org/researchers/nicoletta-colombo/)
- [Ignace Vergote](https://scholariq.org/researchers/ignace-vergote/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.